Sign in
Taking people in United StatesNo phase

Using MRI scans to guide treatment of blocked leg arteries

Studies MRI scans of artery plaque in people with peripheral arterial disease.

Key facts

Who runs it
The Methodist Hospital Research Institute
Where
Houston, United StatesSee the site
Trial code
Registry title
MRI Guided Management of Occlusive Peripheral Arterial Disease
Status
Recruiting
People taking part
175 people, planned
Started
1 Jul 2024
Expected to end
Jun 2029
Type of study
Observational, 2 groups
Record updated
19 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with peripheral arterial disease (narrowed leg arteries) who are having a planned procedure to open the arteries, or a leg amputation. An MRI scan will look at the plaque in the artery.

Age
18 years or older.
Sex
All sexes can join.
Disease stage
Peripheral arterial disease, Rutherford Category 4, 5 or 6 (pain at rest, sores or tissue loss). At least 1 narrowed spot below the knee in the person's own arteries, in one or both legs. The narrowing must be more than 50%, in an artery 2.0 - 4.0 mm wide.

Main reasons for not taking part

  • Rutherford category 0, 1, 2 or 3 in the leg being studied.
  • Not able to have an MRI scan.
  • Not giving written consent.
  • For the amputation part (Aim 2) only: arteries that are fully blocked for a long time (chronic total occlusions).

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • General Inclusion Criteria:
  • All patients will be ≥ 18 years old with PAD (Rutherford Category 4, 5, 6)
  • Anatomic inclusion criteria:
  • At least 1 target lesion below-the-knee in native vessels in one or both limbs ii. Target lesion reference vessel diameter between 2.0 - 4.0 mm by investigator visual estimate iii. Target lesion with > 50% stenosis by investigator visual estimate

Who cannot take part

  • Rutherford category 0, 1, 2, 3 of target limb, Failure or refusal to provide written informed consent, MRI Contraindications
  • General Exclusion Criteria:
  • Anatomic Exclusion Criteria:
  • Aim 2 only - Chronic total occlusions

Where in United States

  • Houston Methodist HospitalHouston, United StatesContact: Trisha Roy, MD, PhDTaking people

About the trial

What the trial wants to find out

The goal of this observational study is to identify which plaque lesions in patients with peripheral arterial disease are impenetrable and to determine which devices minimize vessel wall injury.

Read full original descriptionShow less

Patients undergoing intervention will have an MRI scan prior to their planned percutaneous vascular intervention to assess the plaque and predict procedural difficulty.

Patients undergoing lower limb amputation due to peripheral arterial disease will have their limbs included into a second arm of the study The limb will undergo an MRI scan to assess the plaque. The investigator will then test two different devices and assess the effects of these devices on the vessel wall.

The 2 groups in the trial

  • Amputation Arm

    In an ex vivo human cadaveric model, post-PVI histopathologic analysis will be used to uncover the impact of plaque type on device safety (POBA versus atherectomy) and performance, facilitating evidence-based device selection to mitigate complications. Using a randomized approach, the investigator will compare plain balloon angioplasty to orbital atherectomy prior to angioplasty in amputated legs from PAD patients with plaques characterized into 4 categories based their MRI-histology: concentric calcium, eccentric calcium, fibrous plaque, and soft plaques (smooth muscle and thrombus).

  • Revascularization Arm

    Patient Imaging Protocol: Scans will be performed on 100 patients enrolled into the study population using a 3T MAGNETOM scanner (Siemens) at the Houston Methodist Research Institute Translational Imaging Center. The investigator will use pre-operative images captured using the optimized MRI-histology sequences to score lesions. Physicians performing PVI will be blinded to the pre-operative MRI-histology images and anatomic scores and will make treatment decisions based on their standard of care. The investigator expect MRI-histology plaque scores predict which patients will have PVI failures due to untraversable plaque, and it may also foresee the potential need of adjunctive devices or alternative approaches for successful PVI

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
MRI Guided Management of Occlusive Peripheral Arterial Disease
Plain-language title
Using MRI scans to guide treatment of blocked leg arteriesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
19 March 2026